je.st
news
Vertex sells Incivo royalty rights for $152M
2013-11-20 18:00:19| Biotech - Topix.net
Vertex Pharmaceuticals Inc. is selling its product royalty rights for the hepatitis C treatment Incivo for $152 million to Johnson & Johnson subsidiary Janssen Pharmaceutica.
Tags: rights
sells
royalty
vertex
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||